Aurobindo Pharma USA Inc completes acquisition of Lannett Company, Inc

Aurobindo Pharma USA Inc., (APUSA), a wholly owned subsidiary of Aurobindo Pharma Limited, has announced the successful completion of its acquisition of Lannett Company, Inc., USA ("Lannett"), from Lannett Seller Holdco, Inc., following receipt of approval from the U.S. Federal Trade Commission on June 18, 2026.

Effective June 29, 2026, Lannett has become a wholly owned subsidiary of APUSA and will operate as Lannett Company LLC.

The integration process will commence immediately, with a strong emphasis on ensuring uninterrupted access to critical medications, maintaining trusted relationships with partners, and supporting employees throughout the transition. By combining capabilities and resources, the organization aims to enhance the availability of essential medicines and deliver sustained, long-term value to patients, customers, and stakeholders.

APUSA is also pleased to welcome more than 400 Lannett employees to its organization, further strengthening its talent base and operational capabilities.

We extend our sincere appreciation to Lannett's management team for their leadership in enabling a smooth transition, as well as for their valuable contributions to the organization.

Shares of Aurobindo Pharma Limited was last trading in BSE at Rs. 1575.85 as compared to the previous close of Rs. 1548.85. The total number of shares traded during the day was 200118 in over 10163 trades.

The stock hit an intraday high of Rs. 1588.50 and intraday low of 1548.90. The net turnover during the day was Rs. 315016548.00.

Source : Equity Bulls

Keywords

AurobindoPharma INE406A01037 Pharmaceuticals USA Subsidiary Acquisition Complete LannettCompanyInc